DOCUSIGN, INC. director Solvik Peter exercised Options for 1,096 shares at $0 on 2026-09-01. For investors, the transaction leaves his reported holdings at 10,066 shares and 3,288 derivative securities, clarifying his post-transaction ownership position in the company.
Key Highlights
- Solvik Peter held 10,066 DOCUSIGN, INC. Shares after the transaction.
- His post-transaction position included 3,288 derivative securities.
- The transaction was recorded on 1 September 2026 under transaction code M.
DOCUSIGN, INC. (NASDAQ: DOCU) director Solvik Peter exercised options for 1,096 shares at $0 on 1 September 2026. The transaction was recorded under transaction code M. Peter’s reported ownership after the exercise included 10,066 shares.
$0 Option Exercise Covers 1,096 Shares
The transaction involved Solvik Peter’s exercise of options covering 1,096 DOCUSIGN, INC. Shares. The stated exercise price was $0 per share. The transaction code associated with the exercise was M, and the date recorded was 1 September 2026. Peter also exercised options for 1,096 derivative securities on the same date. His reported post-transaction holdings included 3,288 derivative securities. The ownership figures were reported following the transaction.
FAQs
Q: How many DocuSign shares did Peter Solvik exercise?
A: DocuSign director Peter Solvik exercised options for 1,096 shares. The reported exercise price was $0 per share, with the transaction dated 1 September 2026.
Q: What did the DocuSign director own after the transaction?
A: The Form 4 states that Peter Solvik owned 10,066 DocuSign shares after the transaction. His reported holdings also included 3,288 derivative securities following the transaction.
Q: When did the DocuSign option exercise occur?
A: The DocuSign option exercise occurred on 1 September 2026. The transaction was recorded under code M and involved options for 1,096 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.